Margariti A - Search Results

1

Vascular organoids: unveiling advantages, applications, challenges, and disease modelling strategies.

Naderi-Meshkin H, Cornelius VA, Eleftheriadou M, Potel KN, Setyaningsih WAW, Margariti A. Naderi-Meshkin H, et al. Among authors: margariti a. Stem Cell Res Ther. 2023 Oct 10;14(1):292. doi: 10.1186/s13287-023-03521-2. Stem Cell Res Ther. 2023. PMID: 37817281 Free PMC article. Review.

2

The RNA-binding protein QKI controls alternative splicing in vascular cells, producing an effective model for therapy.

Caines R, Cochrane A, Kelaini S, Vila-Gonzalez M, Yang C, Eleftheriadou M, Moez A, Stitt AW, Zeng L, Grieve DJ, Margariti A. Caines R, et al. Among authors: margariti a. J Cell Sci. 2019 Aug 15;132(16):jcs230276. doi: 10.1242/jcs.230276. J Cell Sci. 2019. PMID: 31331967

3

Diabetic endotheliopathy: RNA-binding proteins as new therapeutic targets.

Cornelius VA, Yacoub A, Kelaini S, Margariti A. Cornelius VA, et al. Among authors: margariti a. Int J Biochem Cell Biol. 2021 Feb;131:105907. doi: 10.1016/j.biocel.2020.105907. Epub 2020 Dec 26. Int J Biochem Cell Biol. 2021. PMID: 33359016 Review.

4

Alternative Splicing: A Key Mediator of Diabetic Vasculopathy.

Cornelius VA, Fulton JR, Margariti A. Cornelius VA, et al. Among authors: margariti a. Genes (Basel). 2021 Aug 27;12(9):1332. doi: 10.3390/genes12091332. Genes (Basel). 2021. PMID: 34573314 Free PMC article. Review.

5

3D-printed reservoir-type implants containing poly(lactic acid)/poly(caprolactone) porous membranes for sustained drug delivery.

Korelidou A, Domínguez-Robles J, Magill ER, Eleftheriadou M, Cornelius VA, Donnelly RF, Margariti A, Larrañeta E. Korelidou A, et al. Among authors: margariti a. Biomater Adv. 2022 Aug;139:213024. doi: 10.1016/j.bioadv.2022.213024. Epub 2022 Jul 9. Biomater Adv. 2022. PMID: 35908473 Free article.

6

RNA-Binding Proteins: Emerging Therapeutics for Vascular Dysfunction.

Cornelius VA, Naderi-Meshkin H, Kelaini S, Margariti A. Cornelius VA, et al. Among authors: margariti a. Cells. 2022 Aug 11;11(16):2494. doi: 10.3390/cells11162494. Cells. 2022. PMID: 36010571 Free PMC article. Review.

7

Effects of non-coding RNAs and RNA-binding proteins on mitochondrial dysfunction in diabetic cardiomyopathy.

Potel KN, Cornelius VA, Yacoub A, Chokr A, Donaghy CL, Kelaini S, Eleftheriadou M, Margariti A. Potel KN, et al. Among authors: margariti a. Front Cardiovasc Med. 2023 Sep 1;10:1165302. doi: 10.3389/fcvm.2023.1165302. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37719978 Free PMC article. Review.

8

Endothelial Cells Derived From Patients With Diabetic Macular Edema Recapitulate Clinical Evaluations of Anti-VEGF Responsiveness Through the Neuronal Pentraxin 2 Pathway.

Vilà González M, Eleftheriadou M, Kelaini S, Naderi-Meshkin H, Flanagan S, Stewart S, Virgili G, Grieve DJ, Stitt AW, Lois N, Margariti A. Vilà González M, et al. Among authors: margariti a. Diabetes. 2020 Oct;69(10):2170-2185. doi: 10.2337/db19-1068. Epub 2020 Aug 13. Diabetes. 2020. PMID: 32796081

9

Fused deposition modelling for the development of drug loaded cardiovascular prosthesis.

Martin NK, Domínguez-Robles J, Stewart SA, Cornelius VA, Anjani QK, Utomo E, García-Romero I, Donnelly RF, Margariti A, Lamprou DA, Larrañeta E. Martin NK, et al. Among authors: margariti a. Int J Pharm. 2021 Feb 15;595:120243. doi: 10.1016/j.ijpharm.2021.120243. Epub 2021 Jan 21. Int J Pharm. 2021. PMID: 33484923

10

RNA-Binding Proteins Hold Key Roles in Function, Dysfunction, and Disease.

Kelaini S, Chan C, Cornelius VA, Margariti A. Kelaini S, et al. Among authors: margariti a. Biology (Basel). 2021 Apr 24;10(5):366. doi: 10.3390/biology10050366. Biology (Basel). 2021. PMID: 33923168 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page